Samlyn Capital, LLC Intra Cellular Therapies, Inc. Transaction History

Samlyn Capital, LLC

$6.21 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $3.21 Million - $4.5 Million	75,073 Added 16.22%	537,888 $25 Million
Q2 2022 Aug 15, 2022	SELL	$43.0 - $65.64 $915,384 - $1.4 Million	-21,288 Reduced 4.4%	462,815 $26.4 Million
Q1 2022 May 16, 2022	SELL	$38.74 - $62.09 $24.2 Million - $38.9 Million	-625,752 Reduced 56.38%	484,103 $29.6 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $5.42 Million - $8.22 Million	-153,861 Reduced 12.18%	1,109,855 $58.1 Million
Q3 2021 Nov 15, 2021	BUY	$28.72 - $42.49 $3.91 Million - $5.78 Million	136,101 Added 12.07%	1,263,716 $47.1 Million
Q2 2021 Aug 16, 2021	SELL	$29.3 - $44.5 $7.09 Million - $10.8 Million	-241,991 Reduced 17.67%	1,127,615 $46 Million
Q1 2021 May 17, 2021	SELL	$30.8 - $39.51 $8.94 Million - $11.5 Million	-290,332 Reduced 17.49%	1,369,606 $46.5 Million
Q4 2020 Feb 16, 2021	SELL	$23.34 - $32.22 $1.69 Million - $2.33 Million	-72,427 Reduced 4.18%	1,659,938 $52.8 Million
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $9.75 Million - $17.6 Million	553,798 Added 46.99%	1,732,365 $44.5 Million
Q2 2020 Aug 14, 2020	BUY	$14.35 - $26.64 $361,203 - $670,555	25,171 Added 2.18%	1,178,567 $30.3 Million
Q1 2020 May 15, 2020	BUY	$12.31 - $33.12 $10.9 Million - $29.4 Million	886,696 Added 332.47%	1,153,396 $17.7 Million
Q4 2019 Feb 14, 2020	SELL	$7.26 - $38.49 $6.63 Million - $35.1 Million	-912,983 Reduced 77.39%	266,700 $9.15 Million
Q3 2019 Nov 14, 2019	BUY	$7.47 - $14.03 $1.1 Million - $2.07 Million	147,578 Added 14.3%	1,179,683 $8.81 Million
Q2 2019 Aug 14, 2019	SELL	$10.65 - $14.29 $3.52 Million - $4.73 Million	-330,981 Reduced 24.28%	1,032,105 $13.4 Million
Q1 2019 May 15, 2019	BUY	$10.9 - $14.09 $1.06 Million - $1.37 Million	96,948 Added 7.66%	1,363,086 $16.6 Million
Q4 2018 Feb 14, 2019	BUY	$10.36 - $20.96 $5.13 Million - $10.4 Million	494,918 Added 64.17%	1,266,138 $14.4 Million
Q3 2018 Nov 14, 2018	SELL	$17.77 - $22.9 $3.89 Million - $5.02 Million	-219,061 Reduced 22.12%	771,220 $16.7 Million
Q2 2018 Aug 14, 2018	BUY	$17.33 - $23.4 $5.82 Million - $7.86 Million	335,938 Added 51.34%	990,281 $17.5 Million
Q1 2018 May 15, 2018	SELL	$15.16 - $25.49 $5.31 Million - $8.93 Million	-350,413 Reduced 34.88%	654,343 $13.8 Million
Q4 2017 Feb 14, 2018	BUY	$14.27 - $16.79 $3.64 Million - $4.28 Million	255,077 Added 34.02%	1,004,756 $14.5 Million
Q3 2017 Nov 14, 2017	BUY	$10.77 - $22.1 $8.07 Million - $16.6 Million	749,679	749,679 $11.8 Million

Others Institutions Holding ITCI

# of Institutions

390

Shares Held

88.9M

Call Options Held

202K

Put Options Held

114K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12.1B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samlyn Capital, LLC with notifications on news.

Account